Desensitization offers hope to highly HLA-sensitized patients for a longer life expectancy after incompatible kidney transplant

American Journal of Kidney Diseases

Volumn 59, Issue 6, 2012, Pages 758-760

  Jordan, Stanley C ^a   Vo, Ashley A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; DESENSITIZATION; GLOMERULOPATHY; HISTOCOMPATIBILITY; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LIFE EXPECTANCY; NOTE; PLASMAPHERESIS; SURVIVAL;

EID: 84861343585     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.02.322     Document Type: Editorial

References (18)

1. R. Shapiro Reducing antibody levels in patients undergoing transplantation N Engl J Med 359 3 2008 305 306
2. United Network for Organ Sharing (home page) Transplant rates by PRA status http://www.unos.org Accessed December 19, 2011
3. R.A. Montgomery, B.E. Lonze, K.E. King Desensitization in HLA-incompatible kidney recipients and survival N Engl J Med 365 4 2011 318 326
4. J.L. Platt Antibodies in transplantation Discov Med 10 51 2010 125 133
5. P.C. Lee, P.I. Terasaki, S.K. Takemoto All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies Transplantation 74 8 2002 1192 1194
6. R. Patel, P.I. Terasaki Significance of the positive crossmatch test in kidney transplantation N Engl J Med 280 14 1969 735 739
7. S.C. Jordan, D. Tyan, D. Stablein Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial J Am Soc Nephrol 15 12 2004 3256 3262
8. R.A. Montgomery, A.A. Zachary, L.C. Racusen Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into crossmatch positive recipients Transplantation 70 6 2000 887 895
9. A.A. Vo, M. Lukovsky, M. Toyoda Rituximab and intravenous immune globulin for desensitization during renal transplantation N Engl J Med 359 3 2008 242 251
10. K. Marfo, A. Lu, M. Ling, E. Akalin Desensitization protocols and their outcome Clin J Am Soc Nephrol 6 4 2011 922 936
11. J.M. Garonzik Wang, R.A. Montgomery Incompatible live-donor kidney transplantation in the United States: results of a national survey [published online ahead of print July 23, 2011] Clin J Am Soc Nephrol 6 8 2011 2041 2046
12. A.A. Vo, A. Peng, M. Toyoda Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation Transplantation 89 9 2010 1095 1102
13. C.H. Lai, K. Cao, G. Ong Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy Transplantation 92 1 2011 48 53
14. N. Shehata, V.A. Palda, R.M. Meyer The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline Transfus Med Rev 24 suppl 1 2010 S7 S27
15. P.D. Hughes, S.J. Cohney Modifiers of complement activation for prevention of antibody-mediated injury to allografts Curr Opin Organ Transplant 16 4 2011 425 433
16. S.C. Jordan, M. Toyoda, A.A. Vo Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation Expert Rev Clin Immunol 7 3 2011 341 348
17. S.C. Jordan, J. Kahwaji, M. Toyoda, A. Vo B-Cell immunotherapeutics: emerging roles in solid organ transplantation Curr Opin Organ Transplant 16 4 2011 416 424
18. R.A. Montgomery, B.E. Lonze, A.M. Jackson Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients Curr Opin Organ Transplant 16 4 2011 439 443